Drug
Plasma Derived Fviii Vwf Concentrate
Plasma Derived Fviii Vwf Concentrate: highest development phase Post-Market, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| plasma-derived FVIII/VWF concentrate NCT02472665 | Post-Market | Von Willebrand Disease |
Latest
No recent events.
Follow Plasma Derived Fviii Vwf Concentrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.